Rhizomelic PseudopolyarthritisSymptoms, Doctors, Treatments, Advances & More
Rhizomelic Pseudopolyarthritis Overview
Learn About Rhizomelic Pseudopolyarthritis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Mayo Clinic-Rochester
Eric Matteson is a Rheumatologist practicing medicine in Virginia Beach, Virginia. Dr. Matteson is rated as an Elite provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Giant Cell Arteritis (GCA), Temporal Arteritis, and Tissue Biopsy. Dr. Matteson is currently accepting new patients.
OSF Medical Group - Rheumatology
Imran Umer is a Rheumatologist practicing medicine in Peoria, Illinois. Dr. Umer is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Tissue Biopsy. Dr. Umer is board certified in American Board Of Internal Medicine. Dr. Umer is currently accepting new patients.
Bassett Health Center Norwich
David Griger is a Rheumatologist practicing medicine in Norwich, New York. Dr. Griger is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Paget's Disease of Bone, Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica. Dr. Griger is currently accepting new patients.
Summary: Polymyalgia rheumatic (PMR) is an inflammatory rheumatic disease affecting the elderly. The diagnosis is based on established ACR/EULAR classification criteria. The activity of the disease is evaluated using the PMR-AS, a disease activity score based on morning stiffness, ability to elevate the upper limbs, physician's global disease assessment and pain assessment measured by the patient using VAS...
Summary: This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w (once every two weeks) or at 200 mg q2w, each given with a 52-week prednisone taper, is superior to placebo given with a 52-week prednisone taper in participants with early polymyalgia rheumatica (PMR) and to determine the safety and tolerab...

